Tiamulin fumarate CAS:55297-96-6

Tiamulin fumarate is indicated for the treatment of swine respiratory diseases, including swine dysentery caused by Brachyspira hyodysenteriae and pneumonia associated with Actinobacillus pleuropneumoniae. In poultry, it is used to control infections such as mycoplasmosis and necrotic enteritis caused by Clostridium perfringens. The dosage and administration of tiamulin fumarate vary based on the animal species, weight, and severity of the infection. It is often administered orally through feed or water for convenient dosing in large groups of animals. In severe cases, injectable formulations may be used for rapid therapeutic effects. Adverse effects associated with tiamulin fumarate therapy are generally mild and may include gastrointestinal disturbances and injection site reactions. Overdoses can lead to toxicity, manifesting as gastrointestinal upset, dehydration, and neurologic signs. It is important to follow dosing instructions carefully and avoid misuse of the medication. Regular monitoring of treatment efficacy and potential development of resistance are crucial aspects of tiamulin fumarate use to ensure successful treatment outcomes and prevent the emergence of resistant bacterial strains. Veterinarians play a key role in overseeing therapy, providing guidance on appropriate dosing regimens, and promoting responsible antibiotic use to optimize animal health and welfare.